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Abstract A second member of the parvulin family of peptidyl-
prolyl cis/trans isomerases was identified in a human lung cDNA
library. The gene encoded a protein named hPar14 that has 131
amino acid residues and a molecular mass of 13 676 Da.
Sequence comparison showed 34.5% identity to E. coli Par10
and 34% identity to human Pin1 (hPar18) within a C-terminal
region of 87 or 120 amino acid residues, respectively. In
comparison to the E. coli Par10, hPar14 possesses a N-terminal
extension of 41 amino acid residues. This extension does not
contain a polyproline II helix-binding motif typical of the known
eukaryotic parvulins. The hPar14 does not accelerate the cis to
trans interconversion of oligopeptides with side chain-phospho-
rylated Ser(Thr)-Pro moieties as hPin1 did. In contrast, it
showed preference of an arginine residue adjacent N-terminal to
proline. Northern blot analysis revealed expression of the gene
within various human tissues like heart, placenta, liver, kidney
and pancreas.
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1. Introduction
The third family of peptidyl prolyl cis/trans isomerases
(PPIases) [1,2], the parvulins, has been established after de-
scription of the prototypic enzyme (E. coli Par10) found in the
Escherichia coli cytosol [3]. By a database search, a group of
proteins or genes encoding proteins could be identi¢ed show-
ing highly signi¢cant similarity with the sequence of the cata-
lytic core of parvulin [4,28], establishing HILVK, (X)33ÿ58,
GGDLGWF, (X)29ÿ31, GXHII as common motifs.
Especially some of the prokaryotic members of this group
were found to be involved in maturation, transport or assem-
bly of speci¢c proteins [5^11].
Recently, a parvulin homologous protein was identi¢ed in
human tissue termed Pin1 [12]. This protein shows a strong
relationship to a yeast essential protein, PTF1/ESS1 [13^15].
Depletion of the Pin1 or PTF1/ESS1 genes from HeLa cells or
yeast disturbed the cell division by inducing mitotic arrest
[12]. Unlike prokaryotic parvulins, Pin1 from human, PTF1/
ESS1 from Saccharomyces cerevisiae, Dodo from Drosophila
melanogaster [16], Pin1 from Aspergillus nidulans [17], PinA
from Dictyostelium discoideum and Ssp1 from Neurospora
crassa [18] share sequence features which N-terminally medi-
ate protein/protein interactions by a WW domain. The WW
domain consists of 35^40 amino acid residues. Four conserved
aromatic residues (two of which tryptophan) are the dominant
characteristic of this sequence motif which was found in a
number of unrelated proteins [19,20].
Interaction between Pin1 from human and from A. nidulans
and many phosphoproteins of the mitotic cycle were shown
exclusively in their phosphorylated state [21^23]. This ¢ts the
enzymatic properties of all the eukaryotic parvulins men-
tioned above: Pin1 from human, Ssp1 from N. crassa and
PTF1/ESS1 from S. cerevisiae are highly speci¢c for the oli-
gopeptide substrate with phosphorylated serine or threonine
residues preceding proline [15,18,24,25].
The crystal structure of hPin1 complexed with Ala-Pro and
a sulfate ion [21] shows a basic cluster composed of two argi-
nine residues (Arg-68, Arg-69) and a lysine residue (Lys-63).
This cluster may be responsible for the preferable recognition
and catalysis of substrates containing negatively charged ami-
no acid residues preceding proline. The conservation of these
residues in the catalytic core of the eukaryotic parvulins be-
comes obvious by multiple sequence alignment of parvulin
sequences.
In this paper we describe the identi¢cation, cloning and
enzymatic characterization of a human parvulin (hPar14),
the ¢rst eukaryotic member of the parvulin family of PPIases
lacking any protein-binding motif supplemented to the cata-
lytic core.
2. Materials and methods
2.1. Database search and cloning of human parvulin
E. coli Par10 (P39159) and hPin1 (hPar18) (U49070) were used
performing a search for additionally human parvulins in the EMBL
GenBank. Two primers were designed for RT-PCR deriving from the
obtained clones (hPar1: 5P-TTT GGA TCC ATG CCG CCC AAA
GGA AAA AG and hPaar2: 5P-TTT GAA TTC TTA TTT TCT
TCC TTC GAC CA). PCR was performed by denaturing the
cDNA at 98‡C for 1 min, following 25 cycles of ampli¢cation (98‡C
for 15 s, 65‡C for 15 s, 74‡C for 30 s) and a ¢nal extension step at
74‡C for 10 min. The PCR product was used screening the human
lung cDNA library (VZAPII, Clonetech, Heidelberg, Germany).
Plaques were transferred to nitrocellulose ¢lters which were treated
with 1.5 M NaCl, 0.5 M NaOH for 1 min, followed with 1.5 M NaCl,
0.5 M Tris-HCl (pH 8.0) for 3 min and ¢nally with 0.2 M Tris-HCl
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(pH 8.0) for 5 min. Filters were exposed for 2 h to 80‡C in a vacuum
oven and pre-hybridized at 42‡C for 4 h in 0.1 M Pipes bu¡er pH 7.5
containing 0.8 M NaCl, 5UDenhardt’s solution, 100 Wg/ml salmon
sperm DNA and 50% formamide. Hybridization was performed with
[K-32P]dCTP labelled full length human parvulin. After autoradiogra-
phy, recombinant phages from positive plaques were sequenced.
The database search and alignments were performed using the mul-
tiple alignment program packages of Genetyx version 9 (Software
Development, Tokyo, Japan). Sequence comparison of various parvu-
lins was performed with the CLUSTALW-program [31].
2.2. Northern Blot analysis
The membrane (Clontech type I membrane (Clontech, Heidelberg,
Germany)) was hybridized with the [K-32P]dCTP labelled full length
human parvulin for 10 h at 42‡C in 50% formamide, 5UDenhardt’s
solution, 5USSC, 0.1% SDS and 100 Wg/ml salmon sperm DNA. This
¢lter was washed three times with 0.2USSC containing 0.1% SDS and
for 20 min at 62‡C. After 3 h, the exposed membrane was analyzed by
BAS 1000 (Fuji Film, Tokyo, Japan). A human multiple tissue North-
ern (MTN) blot was used.
2.3. Expression of human parvulin gene in E. coli
The DNA sequence of the human parvulin gene was ampli¢ed using
cDNA from human endothelial cells and two primers corresponding
to the 5P and the 3P region of the gene (5P-GATCGAGCATGCCG-
CCCAAAGGAAAAAGTGGTTC-3P and 5P-GATCGAAAGCTTA-
TTTTCTTCCTTCGACCATAAT-3P). The resulting PCR product
was puri¢ed by agarose gel electrophoresis, digested with SphI/Hin-
dIII and ligated into the vector pQE70 (Qiagen, Hilden, Germany).
Restriction endonucleases SphI and HindIII and T4 ligase were pur-
chased from Boehringer Mannheim and used as recommended by the
manufacturers. After transformation into E. coli, M15/pREP4 re-
combinants were screened by restriction analysis and controlled by
DNA sequencing according to the procedure of the manufacturer.
A positive clone designated as hPTTQ was used for overexpression
of the recombinant human parvulin.
2.4. Protein puri¢cation
Expression cultures were grown in selective 2UYT medium (16 g/l
peptone, 10 g/l yeast extract, 5 g/l NaCl) by inoculation of 1 l with 20
ml of an overnight culture of the appropriate strain. After the induc-
tion of protein expression at A600 = 0.7 with 1 mM IPTG, cells were
shaken for a further 5 h at 37‡C. Cells were harvested by centrifuga-
tion at 4‡C for 15 min at 6000Ug in a Beckmann J2-HC centrifuge.
Sedimented cells were resuspended in 2 mM Tris bu¡er, pH 8.0. Cell
rupture was performed by a SLM Aminco French pressure cell. The
cell lysate was stirred with 0.1% (v/v) benzonase for 15 min at 4‡C and
ultracentrifuged in a Beckmann L8 60M centrifuge at 20 000Ug for 30
min at 4‡C. The supernatant was applied to a Fractogel EMD DEAE-
650(M) column (2.5U20 cm), equilibrated with 2 mM Tris bu¡er, pH
8.0. hPar14 passed the column unbounded and was applied to a
Fractogel TSK AF-blue column (1U6 cm), equilibrated with 2 mM
Tris bu¡er, pH 8.0. Fractions containing hPar14 were obtained by
running a linear gradient from 0 to 3 M KCl in 60 ml 2 mM Tris
bu¡er, pH 8.0. The fractions were pooled and dialyzed for 2 h against
3 l of 10 mM HEPES bu¡er, pH 7.5, containing 0.5 mM DTE. An ion
exchange chromatography was performed using a Fractogel EMD
SO33 650(M) column (1U6 cm) (Merck, Darmstadt, Germany).
The column was equilibrated with 10 mM HEPES bu¡er, pH 7.5.
Protein was applied to the column at a £ow rate of 1.5 ml/min.
hPar14 containing fractions were received by running a linear gradient
from 0 to 1 M KCl in 100 ml 35 mM HEPES bu¡er, pH 7.5. The
homogeneity of hPar14 was con¢rmed by SDS-PAGE (silver stained)
and RP-HPLC.
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Fig. 1. Nucleotide sequence of human parvulin. The predicted protein sequence is depicted below. The reading frame of hPar14 starts at posi-
tion +1 of the nucleotide sequence and ends at position 405. An asterisk denotes the stop codon. The oligonucleotide sequences used as probes
for Northern blot and PCR are underlined. Accession number of the nucleotide sequence is AB009690 (DDBJ/EMBL/GenBank).
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2.5. PPIase assay
Measurements were carried out as described previously [15], using
Suc-Ala-Xaa-Pro-Phe-NH-Np as substrate. Xaa represents a variable
amino acyl residue in the P1 position of various oligopeptide sub-
strates used for investigation of the substrate speci¢city. Reported
data are given as the mean of three^¢ve measurements. Substrates
were purchased from Bachem (Heidelberg, Germany) or prepared
according [25]. Stock solutions of various substrates were made in
dimethyl sulfoxide.
2.6. Inhibition studies
The substrate Suc-Ala-Arg-Pro-Phe-NH-Np was used in the meas-
urements for inhibition studies. FK506 was a gift from Fujisawa
Pharmaceutical, Osaka, Japan. Stock solutions of the inhibitors
were prepared in 50% ethanol. The incubation time was 5 min for
measurements using FK506 and 15 min for measurements with CsA.
Three independent experiments were performed. The PPIase assay
without protease was performed according [26] and investigation of
the acceleration of refolding the carboxy-methylated RNase T1 var-
iant by hPar14 as described in [30].
3. Results and discussion
Genes encoding proteins belonging to the parvulin family of
PPIases occur within archaebacteria, eubacteria and eukary-
otes like yeast, plants and animals.
An analysis of complete genomes for the occurrence of
parvulin-like enzymes seems to be rather arbitrary. However,
it becomes quite obvious that the progenitor sequence of 92
amino acids, representing the entire catalytic core, does solely
exist in the E. coli cytosol. Other parvulins have C-terminal
and N-terminal extensions of variable length usually compris-
ing 59^245 amino acids (Fig. 3). Notably, eukaryotic parvu-
lins all have the catalytic core supplemented by a WW domain
functioning in protein/protein interactions. A parvulin ap-
proaching the E. coli prototypic 10.1 kDa protein in molec-
ular mass has not been identi¢ed in eukaryotes until now.
Some of the eukaryotic parvulins were shown to be essential
like PTF1/ESS1 in Saccharomyces cerevisiae or hPin1 in HeLa
cells [12,13]. But striking to the situation in yeast and HeLa
cells, a Pin1 related gene which was identi¢ed in Drosophila
melanogaster (dodo) was not found to be essential within
transgenic £ies [4].
A database search was performed to screen for additional
parvulin homologous human genes in the EMBL GenBank.
Nucleotide sequences from human Pin1 (hPar18) and E. coli
Par10 were used. A number of six clones could be identi¢ed
by signi¢cant homology (AA418536, W81296, AA471033,
T65915, AA507634, T65797).
By combination of all received sequence information, a hy-
bridization probe was developed for screening a cDNA li-
brary. From a human lung cDNA library, eight clones were
obtained. Clone number 1 contained the full length encoding
sequence of a gene which was veri¢ed by the 5P upstream 5P-
RACE method. The encoding region of the gene consists of
1013 bp and encodes a protein of 131 amino acids (Fig. 1).
A computer similarity search showed the strong relation-
ship of the putative protein to some PPIases of the parvulin
family (Table 1). Because of this sequence homology, the en-
coded protein was assigned to the parvulin family of PPIases
and named hPar14. The gene was expressed in E. coli and the
recombinant protein was puri¢ed to homology using ion ex-
change and a⁄nity chromatography. The integrity of the re-
ceived protein was proved by mass spectrometry and N-ter-
minal sequencing. The experimental molecular mass was
determined to be 13 677 Da which is 228 Da lower than the
gene-derived protein. However, a N-terminal truncation of
two residues (Met-Pro) leads to the close molecular mass of
13 676 Da. This truncated sequence was veri¢ed by Edman
degradation of the protein.
The PPIase-activity of hPar14 was investigated using several
methods. Using the conventional chymotrypsin-coupled assay,
moderate enzymatic activity could be detected with an array
of tetrapeptide substrates (Table 2). This result was con¢rmed
by assays without helper protease [26] and the acceleration of
the refolding rate of the denatured decarboxy-methylated
RNaseT1 variant by hPin14 [30]. A contamination with E.
coli PPIases could be excluded by Western blot analysis and
the insensitivity of the enzymatic activity toward high concen-
trations of the cyclophilin and FKBP inhibitors cyclosporin A
and FK506. From these experiments it arose that hPar14 is
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Table 2
Substrate speci¢city constants (kcat/KM) of hPar14 and comparison of the speci¢city pattern to related PPIases
Xaa hPar14 E. coli Par10 SurA
kcat/KM (/M/s) Relative activity (%) Relative activity (%) Relative activity (%)
Leu 1012 100 100 100
Ala 550 54 40 33
Phe 223 22 74 28
Gln 620 61 24 77
Arg 3950 390 35 N.D
Lys 523 52 14 17
His 137 14 22 27
Substrates were of the type Suc-Ala-Xaa-Pro-Phe-NH-Np: Xaa stands for a variable amino acyl residue. The relative activities were normalized to
the value of kcat/KM of the substrate Suc-Ala-Leu-Pro-Phe-NH-Np. The values for that substrate were estimated as follows: E. coli Par10 kcat/
KM = 1.35/107 M/s and SurA (E. coli Par47) kcat/KM = 1.9/104 M/s. Measurements were performed in 35 mM HEPES bu¡er, pH 7.8, at 10‡C. The
values concerning SurA were calculated from data of [10].
Table 1
Comparison of the hPar14 with the homologous protein sequences
of other parvulins
(*) %Identity Similarity
H.s. Pin1 (59^163) 34.2 75.8
E.c. Par10 (8^92) 34.5 73.6
S.c. PTF1 (64^173) 20.8 79.2
D.m. Dodo (62^166) 40.7 75.9
A.n. Pin1 (73^176) 37.0 79.6
(*)The amino acid boundary of the similarity region.
H.s. Pin1 (Q13526) and H.s. Par14 (AB009690) from H. sapiens, E.c.
Par10 from E. coli, S.c. PTF1 (P22696) from S. cerevisiae, D.m. Dodo
(P54353) from D. melanogaster and A.n. Pin1 (AF0357768) from
A. nidulans.
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completely resistant against these inhibitors as could be in-
ferred for a parvulin.
Using the substrate Suc-Ala-Leu-Pro-Phe-NH-Np, the spe-
ci¢city constant kcat/KM of 1.01/mM/s was determined in the
chymotrypsin-coupled assay for hPar14. This is about four
orders of magnitude lower than the respective value of kcat/
KM for E. coli Par10 and about 10-fold less active than SurA
from E. coli [10] or PrsA from B. subtilis (J.-U. Rahfeld,
unpublished).
A comparison of the relative values of the speci¢city con-
stants for various substrates shows a general pattern as it was
found for E. coli Par10 but a strong preference for a substrate
with the basic arginine residue preceding proline (Suc-Ala-
Arg-Pro-Phe-NH-Np: kcat/KM = 3.95/mM/s) (Table 2). In con-
trast to Pin1 (hPar18) but like E. coli Par10, hPar14 does not
accelerate the cis to trans interconversion of substrates with
phosphorylated amino acid residues preceding proline like Ac-
Ala-Ala-Ser(PO3H2)-Pro-Arg-NH-Np and Ac-Ala-Ala-
Thr(PO3H2)-Pro-Arg-NH-Np. The lack of recognition of
phosphorylated substrates by hPar14 underlines the role of
the basic cluster in other eukaryotic parvulins for phosphoryl-
ated recognition because in hPar14 these residues are substi-
tuted by Glu-46, Ile-51 and Met-52 (Fig. 2).
Analysis of the sequence of hPar14 showed the existence of
the sequence motifs typical of the parvulin catalytic core [28]
(Fig. 2). Like most other parvulins, hPar14 has an N-terminal
extension (Fig. 3) but in contrast to hPin1, a WW domain for
protein/protein interactions or another known protein-binding
motif could not be identi¢ed. Interestingly, using 41 N-termi-
nal amino acid residues of hPar14 in a data base search, about
a 40^50% homology toward glycine-rich sequences of other
proteins like the HMG17 family of non-histone chromosomal
proteins [29] and merozoite surface antigenic proteins was
obtained. The function of these sequence motifs is still un-
known.
A further characteristic feature of hPar14 is the absence of a
cysteine residue within the motif II (Fig. 2). An involvement
of this amino acid residue in the hPin1 catalysis was postu-
lated [21]. Protein variants with a Cys-133 Ala substitution in
hPin1 and the corresponding variant Cys-41 Ala of E. coli
Par10 exhibited enzymatic activities below 1% compared to
the wild-type [21,27]. Other prokaryotic parvulins like SurA
from E. coli and PrsA from B. subtilis share this absence of a
cysteine within this sequence motif. Their PPIase activities
measured using oligopeptide substrates (kcat/KM = 1^10/mM/
s) is rather small compared to the appropriate values of cyclo-
philins and FKBPs (kcat/KM = 0.1^10/WM/s).
In the case of hPin1 it was shown that unspeci¢c substrates
lacking the speci¢c phosphorylated side chain cannot activate
the full catalytic machinery of the enzyme leading to a s 100-
fold reduction of the values of kcat/KM. The low magnitude of
the speci¢city constant of hPar14 of 3.95/mM/s for the most
favorable substrate may indicate that the reminiscent of the
natural binding partner of this parvulin has not yet been
found among the peptides of Table 2. The measured activity
seems to represent only the contribution by the desolvatations
FEBS 21707 15-3-99
Fig. 3. Comparison of the domain structure of hPar14 and some other parvulins. The black colored box indicates the parvulin catalytic core.
Fig. 2. Sequence alignment of some members of the parvulin family of PPIases. The ¢rst line shows the three dimensional structure elements of
hPin1 taken from [21]. Bold letters indicate conserved amino acid residues, the corresponding consensus sequence is shown in the second line.
The three conserved motifs of the PPIase domain are indicated by underlined I, II and III as shown in the third line. E.c. Par10 (P39159), E.c.
SurA (P21202) and E.c. YbaU (P772241) are from E. coli, S.c. PTF1 (P22696) from S. cerevisiae, H.s. Pin1 (Q13526) and H. s. Par14
(AB009690) from H. sapiens, N.c. Ssp1 (AJ0006023) from N. crassa and B.s. PrsA (P24327) from B. subtilis.
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mechanism due to the overall hydrophobicity of the substrate-
binding pocket of the enzyme without the contribution of
speci¢c transition state stabilization of the substrate.
In the case of hPar14, it may be hypothesized that the
positively charged amino acid in the side chain of the peptide
substrate has not yet the correct position.
Northern blot analysis indicated that hPar14 is well-ex-
pressed in various human tissues (Fig. 4). The presence of a
single band of about 1.0 kb was shown (Fig. 4B). Semi-quan-
titative analysis revealed an overall expression of the gene
with a slight reduction in brain and lung compared to heart,
placenta, liver, kidney and pancreas (Fig. 4A).
Attempts are made to identify native substrates and inter-
acting proteins to evaluate the physiological function of this
PPIase.
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Fig. 4. Northern blot hybridization of hPar14 probe with poly(A)+RNAs from various human tissues. (A) human L-actin control, (B) human
parvulin probe. Lanes 1^8 contain, in order, RNA from human heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
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